Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 11 March 2021
Date:
11/03/2021
Location:
Online
This extraordinary meeting is organised in the context of the evaluation ofJcovden (previously COVID-19 Vaccine Janssen) developed by Janssen-Cilag International N.V.
The aim of the meeting is to conclude the evaluation, if possible.
The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.